A breakthrough technology
M-TRAP® Technology is based on the immobilization of antibodies covalently bounded to a porous membrane. Only the red blood cells having the corresponding antigen are fixed into the membrane revealing immediately the reaction.
The procedure:
The M-TRAP® Technology, patented by DIAGAST, relies on the superposition of membranes and has 2 major advantages:
- Since the test antibodies are inside the upper membrane, they never get in direct contact with the user. There is no risk of cross-contamination.
- Since the lower membrane absorbs the liquids of the test (PAD Buffer and sample), the risk of blood exposure is considerably lower.
This simple protocol takes place in 3 steps and in 30 seconds.
1-Activation
1 drop of buffer is dispensed to hydrate the antisera2-Blood dispensing
The blood samples are added into the well3–Revelation
The well is filled with the buffer revealing the reaction
A very broad field of use:
Easy implementation, easy user-friend, easy reading! The M-TRAP® technology has all the assets for optimal results in all conditions, however extreme they may be.
See the vidéos under.
Patient bedside
Blood group control of blood bags
- Pre filled/ coated monoclonal reagents
- No risk of cross-contamination between the reagents
- Use of blood bag segments, patients finger, EDTA/CPD/Heparin tubes
- Clear and colorimetric reactions
- Traceability: results can be saved
Pre-screening of donors
Blood group control of blood bags
- 150 tests / hour*
- Storage up to 25 °C
- Use of multichannel pipettes
- Less repetitive gestures
- Standardized workstation
Ambulances
Blood donation camps
Military
- Portable PAD®: no need of electric power or any equipment, usable in remote areas
- 2 devices used: the PAD® and the PAD® Buffer
- Usable up to 40 °C